Drugs / Acetylsalicylic Acid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02183688 | Sep 1998 → Jan 2003 | migraine disorder | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acetylsalicylic Acid | “Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients” NCT02183688 ↗ |
| Known as | ASA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02183688 ↗ |
| Route | Oral | “ASA, paracetamol, caffeine, and placebo administered orally” NCT02183688 ↗ |